Biofluid Research on Age-Related or Inherited Neurodegeneration
Public ClinicalTrials.gov record NCT07798700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biofluid Research on Age-Related or Inherited Neurodegeneration (BRAIN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to contribute to and continue to sustain a repository of blood samples, nucleic acid (DNA and/or RNA) samples, family history information, and other demographic information from individuals with age-related neurodegenerative conditions, or their family members who may or may not be at risk for similar conditions. This study will continue to further expand research into the molecular and genetic basis of these diseases and their risk factors.
Study identification
- NCT ID
- NCT07798700
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
- ALS (Amyotrophic Lateral Sclerosis)
- Alzheimer's Disease (AD)
- Cortical Basal Syndrome (CBS)
- Dementia With Lewy Bodies (DLB)
- Familial Frontotemporal Lobar Degeneration (fFTLD)
- Fronto-temporal Lobar Dementia
- Frontotemporal Degeneration (FTD)
- Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)
- Parkinson's Disease (PD)
- Parkinson's Disease Dementia (PDD)
- Posterior Cortical Atrophy (PCA)
- Primary Lateral Sclerosis (PLS)
- Primary Muscular Atrophy (PMA)
- Primary Progressive Aphasia (PPA)
- Progressive Supranuclear Palsy(PSP)
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2025
- Primary completion
- Dec 31, 2069
- Completion
- Dec 31, 2069
- Last update posted
- Aug 31, 2026
2025 – 2070
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated ALS (Amyotrophic Lateral Sclerosis) trials
Other public records listing ALS (Amyotrophic Lateral Sclerosis). Sorted by last update posted; newest first. Not a recommendation.
- NCT07543367: INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study Recruiting
- NCT07295990: Tongue-strengthening Exercises in People With ALS. Recruiting
- NCT07407725: Clinical Outcome Assessment for AT & BCI Recruiting
- NCT07491562: Evaluation of a Structurally Suitable Neck Exoskeleton in Patients With Amyotrophic Lateral Sclerosis Recruiting
- NCT07294144: Tofersen in Non-SOD1 ALS Recruiting
- NCT06649955: Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07798700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07798700 live on ClinicalTrials.gov.